CMS’s 2027 Modifier 25 Proposal Sparks Outrage: Will Same-Day Care Survive the 50% Cut?

The convenience of getting evaluated and treated in a single doctor’s visit is under severe threat, and the medical community is not staying quiet.

In July 2026, the Centers for Medicare and Medicaid Services (CMS) released the calendar-year 2027 Medicare Physician Fee Schedule (MPFS) proposed rule. While the annual fee schedule always contains complex adjustments, one specific provision has ignited immediate, fierce backlash from physicians and Congress alike: a proposal to slash reimbursement by 50% when a physician performs a separately identifiable evaluation and management (E/M) visit on the same day as a minor procedure.

Under the proposed rule, which would take effect on January 1, 2027, the highest-valued eligible service on that day would be paid at 100%, while payment for any other eligible services—including the E/M visit—would be reduced by 50%.

The Medical Coding and Billing Context

At the center of this controversy is modifier 25, a critical medical coding tool used to indicate that a significant, separately identifiable E/M service was performed by the same provider on the same day as a procedure with a 0-, 10-, or 90-day global period.

Currently, when dealing with HCPCS codes, modifier 25 same day procedure policies dictate that billing teams must ensure their documentation proves the evaluation went above and beyond the usual pre-operative and post-operative work associated with the procedure itself. CMS argues that the current system results in duplicate payments. According to the agency's rationale, when an E/M visit and a procedure happen during the same encounter, they share resources—such as clinical staff time, exam room use, and patient registration—creating "efficiencies" that shouldn't be paid for twice.

However, medical professionals argue that this logic fundamentally misunderstands the clinical reality of diagnosing and treating complex patients.

Financial Impact and Specialty Fallout

The financial toll of the proposed cut would be massive. A recent analysis by Milliman, commissioned by the American Academy of Dermatology Association (AADA), estimated that the proposed modifier 25 policy would reduce Medicare fee-for-service allowed amounts by approximately $969 million (in 2024 terms).

Certain specialties that frequently rely on same-day interventions are bracing for the worst:

• Dermatology: Dermatologists face the largest estimated reduction in absolute dollars, accounting for approximately $291 million—or about 30% of all specialty reductions. For example, if a dermatologist evaluates a patient for a suspicious skin lesion, diagnoses L57.0 actinic keratosis, and decides to perform immediate cryosurgery, the E/M portion of that visit would be cut in half under the new rule.
• Orthopedics and Pain Management: Orthopedic surgeons and pain specialists are also heavily impacted. Consider a physician evaluating a patient whose chart indicates ICD-10 code M19.011 (Primary osteoarthritis, right knee). If the physician performs a thorough evaluation of the worsening joint pain and subsequently administers a therapeutic steroid injection during the same encounter, they would face the 50% penalty on the evaluation.
• Podiatry: The American Podiatric Medical Association (APMA) warned that the rule could cut total podiatric Medicare payments by approximately 6% overall, largely driven by the same-day service penalty.

Patient Access Concerns and Congressional Pushback

The backlash against the CY 2027 proposal mirrors a similar fight from several years ago. CMS proposed a substantially similar policy in 2019 but ultimately scrapped it after immense pressure from healthcare stakeholders.

With the public comment period having closed on September 14, 2026, medical associations—including the American Medical Association (AMA), the Medical Group Management Association (MGMA), and the American Academy of Orthopaedic Surgeons (AAOS)—have flooded CMS with letters urging them to withdraw the proposal. Congress has also stepped in, with bipartisan lawmakers expressing deep concern over the policy's potential to harm patient access to care.

"Beyond the impact to physician reimbursement, this proposed policy could significantly impact patients' access to care by requiring them to receive care over multiple appointments, rather than in a single visit," warned the Washington State Medical Association (WSMA) in a recent advocacy alert.

For elderly Medicare beneficiaries, splitting a single visit into two separate appointments means doubling their travel time, doubling their copays, and delaying necessary treatments.

What Medical Billers Should Do Now

As the healthcare industry waits for the final rule—typically released in early November—medical billing and revenue cycle teams must prepare for heightened scrutiny.

Even if CMS modifies or delays the 50% cut, the aggressive targeting of same-day services means audits will likely increase. Proper documentation of specific ICD-10-CM codes to justify the medical necessity of both the visit and the procedure is more critical than ever. Practices should begin auditing their own modifier 25 utilization now, ensuring that every same-day E/M visit clearly stands alone in the medical record.

Whether CMS finalizes the rule as written or bows to congressional pressure, one thing is certain: the battle over how Medicare values a physician's time and clinical judgment is far from over.